Dermatology NewsTopical PDE-4 inhibitor for psoriasis effective in phase 2b trialJuly 14, 2020Psoriasis
Eczema Herpeticum in a Patient With Hailey-Hailey Disease Confounded by Coexistent PsoriasisJuly 8, 2020PsoriasisInfectious Diseases
Variations in Preference for Topical Vehicles Among Demographic GroupsJuly 8, 2020AcnePsoriasisAtopic Dermatitis
Dermatology NewsRisankizumab compared with secukinumab in 52-week psoriasis trialJune 23, 2020PsoriasisPsoriatic Arthritis
Dermatology NewsPsoriasis topical combination maintenance strategy hits mark in phase 3June 16, 2020PsoriasisPsoriatic Arthritis
Daily Recap: FDA revokes emergency use of hydroxychloroquine; Hardest hit specialties ranked in financial reportJune 15, 2020COVID-19 UpdatesBusiness of MedicinePsoriasis
Dermatology NewsResults from two phase 3 trials of bimekizumab unveiledJune 15, 2020PsoriasisPsoriatic Arthritis
Dermatology NewsBiologics may carry melanoma risk for patients with immune-mediated inflammatory diseasesJune 8, 2020MelanomaPsoriasisPsoriatic Arthritis
Dermatology NewsBiologics yield low rates of skin clearance in real-world psoriasis studyJune 3, 2020PsoriasisPsoriatic Arthritis
Dermatology NewsFDA approves ixekizumab for nonradiographic axSpAJune 1, 2020Psoriatic ArthritisPsoriasis
Dermatology News‘Loss-frame’ approach makes psoriasis patients more agreeable to treatmentMay 29, 2020PsoriasisPsoriatic Arthritis
Dermatology NewsPsoriasis patients with mental illness report lower satisfaction with physiciansMay 15, 2020PsoriasisMixed TopicsPsoriatic Arthritis
Dermatology NewsCase series suggests biologics, JAK inhibitors safe during pandemicMay 1, 2020Psoriatic ArthritisCOVID-19 UpdatesPsoriasis
